- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aker Biomarine AS (AKBM)
Assess today's live Aker Biomarine AS (AKBM) share price, performance and insights using our live Oslo: AKBM stock exchange data.
Analyse the historical data and Aker Biomarine AS share price performance charts on this page. Our technical summary section provides analysis on Aker Biomarine AS share price buy/sell indicators using real-time data (or discuss the Aker Biomarine AS (AKBM) stock price today with other investors in the Aker Biomarine AS OL share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current OL AKBM share price (ISIN: NO0010886625) to enhance your trading decisions with our free investment tools and resources.
What Is the Aker Biomarine AS Share Price Today?
The Aker Biomarine AS share price today is 59.70.
What Is the Stock Symbol for Aker Biomarine AS
The stock symbol (or 'ticker') for Aker Biomarine AS is "AKBM."
What Stock Exchange Does Aker Biomarine AS Trade On?
Aker Biomarine AS is listed and trades on the Oslo stock exchange.
Is Aker Biomarine AS a Good Stock to Buy?
Determining whether Aker Biomarine AS—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Aker Biomarine AS share price performance charts on this page. Our technical summary section provides analysis on Aker Biomarine AS share price buy/sell indicators using real-time data (or discuss the Aker Biomarine AS (AKBM) stock price today with other investors in the Aker Biomarine AS OL share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current OL AKBM share price (ISIN: NO0010886625) to enhance your trading decisions with our free investment tools and resources.
What Is the Aker Biomarine AS Share Price Today?
The Aker Biomarine AS share price today is 59.70.
What Is the Stock Symbol for Aker Biomarine AS
The stock symbol (or 'ticker') for Aker Biomarine AS is "AKBM."
What Stock Exchange Does Aker Biomarine AS Trade On?
Aker Biomarine AS is listed and trades on the Oslo stock exchange.
Is Aker Biomarine AS a Good Stock to Buy?
Determining whether Aker Biomarine AS—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
59.70
-0.80(-1.32%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
59.50
60.50
52 wk Range
42.30
109.80
AKBM Scorecard
Full Analysis
Net income is expected to grow this year
High dividend Yield
More Info
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
59.5060.50
52 wk Range
42.30109.80
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(75.38%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(75.38%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AKBM Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
56.40
Downside
-5.54%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Liquid assets exceed short term obligations
Aker Biomarine AS Company Profile
Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. It operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business. The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LYSOVETA brand; and marine-origin DHA omega-3 from microalgae under the Revervia brand name, as well as advanced phospholipid technology under PL+ name. The Consumer Health Products segment sells processed and packaged krill, fish, and plants derived raw materials to retailers in the United States. The Emerging Business segment offers krill oil under Kori brand name. The company provides protein solutions under the Understory brand; biostimulants under KRBNX brand; and a therapeutic candidate based on omega-3 to manage and treat cardiometabolic diseases under CaPre brand name, as well as delivers circular products utilizing recycled industrial and marine plastic waste under AION name. Aker BioMarine ASA was founded in 2006 and is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.
Aker Biomarine AS Earnings Call Summary for Q1/2025
- Revenue up 5% YoY to $50.8M; adjusted EBITDA rose to $9M from $5.7M; stock climbed 5.11% pre-market
- Human Health Ingredients segment restructured; corporate costs reduced to $10-12M from $19-20M
- Krill oil expansion targets 40 new customers in 2025; capital expenditure projected at $6-8M
- CEO highlights ninth consecutive quarter of YoY growth; aims for 15-20% market share
- Analysts expect 27% revenue growth in current fiscal year; company projected to return to profitability
Last Updated: 30/04/2025, 08:48
Read Full TranscriptCompare AKBM to Peers and Sector
Metrics to compare | AKBM | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipAKBMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −37.9x | 7.3x | 11.9x | |
PEG Ratio | −0.01 | 0.00 | 0.03 | |
Price/Book | 3.0x | 1.5x | 1.5x | |
Price / LTM Sales | 2.6x | 1.0x | 0.9x | |
Upside (Analyst Target) | −6.2% | 111,683.8% | 17.0% | |
Fair Value Upside | Unlock | 19.1% | 3.8% | Unlock |
Analyst Ratings
1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 56.40
(-5.54% Downside)
Earnings
Latest Release
Apr 30, 2025
EPS / Forecast
-0.01 / 0.01
Revenue / Forecast
50.92M / 56.10M
FAQ
What Is the Aker Biomarine AS (AKBM) Stock Price Today?
The Aker Biomarine AS stock price today is 59.70
What Stock Exchange Does Aker Biomarine AS Trade On?
Aker Biomarine AS is listed and trades on the Oslo Stock Exchange stock exchange.
What Is the Stock Symbol for Aker Biomarine AS?
The stock symbol for Aker Biomarine AS is "AKBM."
Does Aker Biomarine AS Pay Dividends? What’s The Current Dividend Yield?
The Aker Biomarine AS dividend yield is 75.38%.
What Is the Aker Biomarine AS Market Cap?
As of today, Aker Biomarine AS market cap is 5.31B.
What Is Aker Biomarine AS's Earnings Per Share (TTM)?
The Aker Biomarine AS EPS (TTM) is -0.16.
When Is the Next Aker Biomarine AS Earnings Date?
Aker Biomarine AS will release its next earnings report on 10 Jul 2025.
From a Technical Analysis Perspective, Is AKBM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Aker Biomarine AS Stock Split?
Aker Biomarine AS has split 0 times.
How Many Employees Does Aker Biomarine AS Have?
Aker Biomarine AS has 249 employees.
What is the current trading status of Aker Biomarine AS (AKBM)?
As of 12 Jun 2025, Aker Biomarine AS (AKBM) is trading at a price of 59.70, with a previous close of 60.50. The stock has fluctuated within a day range of 59.50 to 60.50, while its 52-week range spans from 42.30 to 109.80.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.